
About Jaunt
We believe great companies are built by passionate resources.
We are dedicated to building up companies who affect individual lives.
A Passionate Team
Jaunt was built on the notion that by exploring all routes, we can better understand where to direct others. We are passionate about intelligence, products, investments, solving critical problems for clients, and we question everything in order to arrive at a solution that works. We believe data is critically important to drive decisions, and it is this coalescence of intelligence and experience that allows truly life-changing products to reach the market and have an impact on people’s lives.

Team

Aaron Call
Aaron has spent his entire career determining strategies for products. Having started in the trenches of engineering, evaluated hundreds of new markets for emerging technology investments and having developed and launched dozens of products, Aaron has experienced every bump on the road to product-market-fit. He has a passion for product strategies and how they influence business success.

Brent Jacobsen
Brent is a visionary, dynamic leader with proven experience driving dramatic acceleration of growth and transformation of business operations, commercial execution, and sales & marketing. With experience in both venture capital funded, startups, and Fortune 500, Brent is passionate about developing talent and commercializing innovative technologies and business models that disrupt the status quo.

Brent Nixon
Brent is a global sales and marketing executive with an impressive history of leading Fortune 100 and start-up companies for over 30 years. His expertise spans the globe providing knowledge for domestic and international sales and marketing strategy as well as next-generation product development. He has launched hundreds of medical technologies creating a history of success among companies.

Shane Brown
Shane is a servant leader with a proven record of producing results in the U.S. and internationally for companies ranging from entrepreneurial startups to Fortune 500 companies. He has a legacy of building cohesive teams and providing strategic direction for the commercialization and early adoption of emerging therapies while maximizing existing products in highly competitive medical device, digital health and medtech markets.
